Search Results - "Peres, Nataly"

Profiling of Tumor-Infiltrating Immune Cells and Their Impact on Survival in Glioblastoma Patients Undergoing Immunotherapy with Dendritic Cells by Peres, Nataly, Lepski, Guilherme A, Fogolin, Carla S, Evangelista, Gabriela C M, Flatow, Elizabeth A, de Oliveira, Jaqueline V, Pinho, Mariana P, Bergami-Santos, Patricia C, Barbuto, José A M

“…Glioblastomas (GBM) are the most common primary malignant brain tumors, comprising 2% of all cancers in adults. Their location and cellular and molecular…”
Get full text

Near-Complete Remission of Glioblastoma in a Patient Treated with an Allogenic Dendritic Cell-Based Vaccine: The Role of Tumor-Specific CD4+T-Cell Cytokine Secretion Pattern in Predicting Response and Recurrence by Pinho, Mariana P, Lepski, Guilherme A, Rehder, Roberta, Chauca-Torres, Nadia E, Evangelista, Gabriela C M, Teixeira, Sarah F, Flatow, Elizabeth A, de Oliveira, Jaqueline V, Fogolin, Carla S, Peres, Nataly, Arévalo, Analía, Alves, Venâncio, Barbuto, José A M, Bergami-Santos, Patricia C

“…Immunotherapy has brought hope to the fight against glioblastoma, but its efficacy remains unclear. We present the case of CST, a 25-year-old female patient…”
Get full text

207 Dendritic Cells Immunotherapy in the Treatment of Glioblastoma by Rehder, Roberta, Lepski, Guilherme A., Barbuto, José A. M., Santos, Patricia C. B., Peres, Nataly, Pinho, Mariana P.

“…INTRODUCTION: Immunotherapy is gradually being established as a relevant adjuvant therapy against cancer. Cell vaccination is a promising strategy for the…”
Get full text

Immunological profiling of glioblastoma cellular composition to predict response to dendritic cell vaccination by Lepski, Guilherme, Peres, Nataly, Santos, Patricia Bergami, Pinho, Mariana, Chauca-Torres, Nadia, Evangelista, Gabriela Coeli, Teixeira, Sarah, Flatow, Elizabeth, de Oliveira, Jaqueline Vaz, Fogolin, Carla, Arévalo, Analía Leonora, Alves, Venâncio A, Barbuto, Alexandre

“…e14037 Background: Glioblastomas are the most common primary malignant brain tumors, comprising 2% of all adult cancers. Despite recent advancements in genetic…”
Get full text

Adjuvant Vaccination with Allogenic Dendritic Cells Significantly Prolongs Overall Survival in High-Grade Gliomas: Results of a Phase II Trial by Lepski, Guilherme, Bergami-Santos, Patricia C, Pinho, Mariana P, Chauca-Torres, Nadia E, Evangelista, Gabriela C M, Teixeira, Sarah F, Flatow, Elizabeth, de Oliveira, Jaqueline V, Fogolin, Carla, Peres, Nataly, Arévalo, Analía, Alves, Venâncio A F, Barbuto, José A M

“…Immunotherapy for cancer treatment has gained increased attention in recent years. Recently, our group reported the case of a patient with glioblastoma who…”
Get full text

Near-Complete Remission of Glioblastoma in a Patient Treated with an Allogenic Dendritic Cell-Based Vaccine: The Role of Tumor-Specific CD4+T-Cell Cytokine Secretion Pattern in Predicting Response and Recurrence by Pinho, Mariana P, Lepski, Guilherme A, Rehder, Roberta, Chauca-Torres, Nadia E, Evangelista, Gabriela C M, Teixeira, Sarah F, Flatow, Elizabeth A, de Oliveira, Jaqueline V, Fogolin, Carla S, Peres, Nataly, Arévalo, Analía, Alves, Venâncio, Barbuto, José A M, Bergami-Santos, Patricia C

Get full text